Article

PTCE and NCODA Partner for Oncology-Focused Continuing Education

PTCE, the industry-leading continuing pharmacy education provider, becomes sole provider for association’s 3 major meetings through 2021.

Pharmacy Times Continuing Education (PTCE) proudly has announced it is now the exclusive continuing education (CE) provider for the National Community Oncology Dispensing Association, Inc. (NCODA) 2020-2021 meetings.

NCODA provides its medically integrated dispensing pharmacy team members with the opportunity to attend their 2 national marquee meeting events, the NCODA Spring Forum and the NCODA Fall Summit. These meetings allow the NCODA membership to share best practices and discuss the present-day oncology landscape. Through this partnership with PTCE, NCODA’s members will gain access to targeted CE programming that supports positive clinical outcomes, interventions, and patient care by exploring treatment and management considerations for patients receiving oncolytics.

“We’re very excited to join forces with NCODA to provide their audiences with high-quality content as their national meeting CE provider,” said Jim Palatine, RPh, MBA, president of PTCE, in a prepared statement. “NCODA’s annual meetings have been a driver of change to improve and advance the medically integrated dispensing pharmacy services for oncology practices. We look forward to using our platforms, as well as expert speakers and resources, to help achieve its goals to enhance education for health care professionals who provide care to patients with cancer.”

PTCE will have exclusivity to provide 6 CE-accredited sessions to NCODA physicians, pharmacists, nurses, and pharmacy technician members at each of the following NCODA meetings:

  • 2020 NCODA National Fall Summit Virtual E-Meeting, Oct. 22-23, 2020.
  • 2021 NCODA National Spring Forum, location, and date TBD.
  • 2021 NCODA National Fall Summit, location, and date TBD.

“We are excited about this partnership,” said Michael Reff, executive director, and founder of NCODA, in a prepared statement. “We know that through working with PTCE, our membership will have many of their needs met from an educational perspective. We look forward to delivering on our mission of being patient-centric and collaborative with the help of our new partner, PTCE.”

PTCE is a brand of MJH Life Sciences™, the largest privately held, independent, full-service medical media company in North America, and parent company to Pharmacy TimesTM.

For more information on joining NCODA and attending NCODA’s 2020 National Fall Summit virtual e-meeting, visit the organization’s website.

REFERENCE

PTCE and NCODA to Partner in Bringing Oncology-Focused Continuing Education to the NCODA Membership [news release]. Cranbury, NJ; August 26, 2020: PTCE. https://www.businesswire.com/news/home/20200826005448/en/PTCE-NCODA-Partner-Bringing-Oncology-Focused-Continuing-Education Accessed August 26, 2020.

Related Videos
Anthony Perissinotti, PharmD, BCOP, discusses unmet needs and trends in managing chronic lymphocytic leukemia (CLL), with an emphasis on the pivotal role pharmacists play in supporting medication adherence and treatment decisions.
Image Credit: © alenamozhjer - stock.adobe.com
pharmacogenetics testing, adverse drug events, personalized medicine, FDA collaboration, USP partnership, health equity, clinical decision support, laboratory challenges, study design, education, precision medicine, stakeholder perspectives, public comment, Texas Medical Center, DNA double helix
pharmacogenetics challenges, inter-organizational collaboration, dpyd genotype, NCCN guidelines, meta census platform, evidence submission, consensus statements, clinical implementation, pharmacotherapy improvement, collaborative research, pharmacist role, pharmacokinetics focus, clinical topics, genotype-guided therapy, critical thought
Image Credit: © Andrey Popov - stock.adobe.com
Image Credit: © peopleimages.com - stock.adobe.com
TRUST-I and TRUST-II Trials Show Promising Results for Taletrectinib in ROS1+ NSCLC
World Standards Week 2024: US Pharmacopeia’s Achievements and Future Focus in Pharmacy Standards